Form 4: Shoulder Innovations COO Exercises Stock Options

Chief Operating Officer Matthew Ahearn exercised stock options to acquire 21,664 shares of Shoulder Innovations common stock.

Summary

• Matthew Ahearn, Chief Operating Officer of Shoulder Innovations, Inc., exercised options to acquire a total of 21,664 shares of common stock on April 20, 2026.
• The transaction involved two separate option exercises: 7,421 shares at a price of $2.4804 and 14,243 shares at a price of $2.862.
• Following these transactions, the reporting person's direct beneficial ownership increased to 286,765 shares.
• The filing also notes the receipt of 49,245 shares via in-kind distributions from various investment entities.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive event, as it reflects an executive increasing their personal investment in the company through the exercise of vested options.

Positives

• The executive is increasing his direct equity stake in the company, signaling confidence in the firm's long-term prospects.
• The exercise of options demonstrates the alignment of management incentives with shareholder interests.

Negatives

• None identified; this is a standard disclosure of executive equity activity.

Risks

• The company is subject to the inherent risks of the medical device industry, including regulatory approval processes and market competition.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a disclosure of insider equity transactions.

Industry Context

StockSavvy.ai notes that insider option exercises are common in the medical device sector as executives manage their personal portfolios and tax obligations, often reflecting confidence in the company's growth trajectory.

Comparison to Industry Standards

• The exercise of vested options is consistent with standard executive compensation practices in the healthcare technology and medical device industries.
• The volume of shares acquired is typical for a C-suite executive at a company of this market capitalization.

Related Party Transactions

• The reporting person received in-kind distributions of 49,245 shares from various investment funds, including Genesis Investment Holdings and Cultivate MD Capital entities.

Stakeholder Impact

• Shareholders may view the increased direct ownership by the COO as a positive signal of management commitment.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Shoulder Innovations, SI, Form 4, Insider Trading, Stock Options, Medical Devices